| Name | Title | Contact Details |
|---|
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
Growth Co Inc is a Anchorage, AK-based company in the Business Services sector.
Rapid Electronics is a Pueblo, CO-based company in the Business Services sector.
BSTPromark is one of the leading providers in Business Services. It is based in Elmhurst, IL. To find more information about BSTPromark, please visit www.bstpromark.com.